COVID-19 booster shots could rake in billions for some vaccine makers

COVID-19 booster shots could rake in billions for some vaccine makers
Larger font Increase article font size


Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans’ protection against the virus.

How much the manufacturers stand to gain depends on how big the rollout proves to be.

Exactly who should get a booster was a contentious decision as advisers to the Centers for Disease Control and Prevention spent two days this week poring over the evidence. CDC director Dr. RochelleWalensky endorsed most of their choices: People 65 and older, nursing home residents and those ages 50 to 64 who have chronic health problems such as diabetes should be offered one once they’re six months past their last Pfizer dose. Those 18 and older with health problems can decide for themselves if they want a booster.

Still, the crisis is constantly evolving, and some top U.S. health officials expect boosters will be more broadly authorized in the coming weeks or months. And that, plus continued growth in initial vaccinations, could mean a huge gain in sales and profits for Pfizer and Moderna in particular.
News Topics :
Similar Articles :
Top Stories
Vaccine makers Moderna Inc and Pfizer Inc, with its German partner BioNTech, have been vocal in their view that the world will soon need COVID 19 booster shots to maintain high...
Pfizer PFE shares traded higher Thursday after the U.S. Food & Drug Administration formally approved its coronavirus vaccine for booster shots in older and at risk Americans. The FDA said...
Larger font Increase article font size A+ U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID 19 vaccine Friday, citing growing worry that Americans who got the single dose shot...
WASHINGTON U.S. regulators on Wednesday signed off on extending COVID 19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for...
U.S. health advisers said Thursday that some Americans who received Moderna s COVID 19 vaccine at least six months ago should get a half dose booster to rev up protection against the...